Search

everythinglearnresearchcommunity

for

Search:↓

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

The spiny mouse is a unique menstruating rodent that can help us understand menstruation and reproductive disorders.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Selenium might help with insulin resistance and cholesterol in PCOS, but more research is needed to confirm its benefits.

The document concludes that more research is needed to fully understand the causes of PCOS.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

New treatments for PCOS focus on managing symptoms and improving fertility.

Transvaginal hydrolaparoscopy is effective for increasing ovulation and pregnancy rates in women with PCOS who didn't respond to clomiphene.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Metformin can cause hair loss in some women with PCOS.

Finasteride and metformin both help treat PCOS, but using them together works best.